2024 Q2 Form 10-Q Financial Statement

#000166299124000143 Filed on May 09, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2024 Q1
Revenue $55.97M $46.98M
YoY Change 60.2% 35.49%
Cost Of Revenue $10.74M $11.79M
YoY Change 35.18% 43.07%
Gross Profit $45.23M $35.19M
YoY Change 67.56% 33.13%
Gross Profit Margin 80.81% 74.91%
Selling, General & Admin $2.522M $2.380M
YoY Change 48.55% -14.95%
% of Gross Profit 5.58% 6.76%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $247.4K $226.8K
YoY Change 20.02% 12.97%
% of Gross Profit 0.55% 0.64%
Operating Expenses $2.522M $2.380M
YoY Change 48.55% -14.95%
Operating Profit $16.70M $13.83M
YoY Change 343.74% 155.26%
Interest Expense -$2.911M $4.081M
YoY Change -174.01% 20.86%
% of Operating Profit -17.43% 29.5%
Other Income/Expense, Net $50.13K -$91.56K
YoY Change -95.35% -180.68%
Pretax Income $13.58M $8.400M
YoY Change 1070.27% 383.83%
Income Tax -$16.12M $393.1K
% Of Pretax Income -118.74% 4.68%
Net Earnings $29.70M $8.007M
YoY Change 2505.94% 364.3%
Net Earnings / Revenue 53.07% 17.04%
Basic Earnings Per Share $5.25 $1.41
Diluted Earnings Per Share $4.93 $1.34
COMMON SHARES
Basic Shares Outstanding 5.667M shares 5.633M shares
Diluted Shares Outstanding 6.024M shares 5.961M shares

Balance Sheet

Concept 2024 Q2 2024 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $58.03M $77.78M
YoY Change -6.54% 31.75%
Cash & Equivalents $58.03M $77.78M
Short-Term Investments
Other Short-Term Assets $12.19M $9.251M
YoY Change 150.18% 75.65%
Inventory
Prepaid Expenses
Receivables $119.2M $103.3M
Other Receivables $1.024M $1.316M
Total Short-Term Assets $190.5M $191.7M
YoY Change 24.75% 26.96%
LONG-TERM ASSETS
Property, Plant & Equipment $865.4K $867.9K
YoY Change 321.43% 219.76%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $402.4K $516.3K
YoY Change -42.0% -27.99%
Total Long-Term Assets $21.61M $4.024M
YoY Change 733.06% 60.74%
TOTAL ASSETS
Total Short-Term Assets $190.5M $191.7M
Total Long-Term Assets $21.61M $4.024M
Total Assets $212.1M $195.7M
YoY Change 36.58% 27.52%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $71.25M $73.73M
YoY Change 5.68% 12.96%
Accrued Expenses $8.440M $10.49M
YoY Change 68.07% 43.94%
Deferred Revenue $3.942M $3.134M
YoY Change 118.66% 91.49%
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $0.00 $0.00
YoY Change
Total Short-Term Liabilities $91.95M $92.94M
YoY Change 16.87% 20.05%
LONG-TERM LIABILITIES
Long-Term Debt $68.88M $71.69M
YoY Change 19.53% 21.61%
Other Long-Term Liabilities $74.07K $580.5K
YoY Change -96.33% -76.93%
Total Long-Term Liabilities $74.07K $580.5K
YoY Change -96.33% -76.93%
TOTAL LIABILITIES
Total Short-Term Liabilities $91.95M $92.94M
Total Long-Term Liabilities $74.07K $580.5K
Total Liabilities $161.8M $166.1M
YoY Change 16.39% 18.8%
SHAREHOLDERS EQUITY
Retained Earnings -$126.0M -$149.9M
YoY Change -22.13% -7.96%
Common Stock $2.084K $2.084K
YoY Change 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $50.29M $29.61M
YoY Change
Total Liabilities & Shareholders Equity $212.1M $195.7M
YoY Change 36.58% 27.52%

Cashflow Statement

Concept 2024 Q2 2024 Q1
OPERATING ACTIVITIES
Net Income $29.70M $8.007M
YoY Change 2505.94% 364.3%
Depreciation, Depletion And Amortization $247.4K $226.8K
YoY Change 20.02% 12.97%
Cash From Operating Activities -$4.395M $38.61M
YoY Change -167.09% -1047.62%
INVESTING ACTIVITIES
Capital Expenditures $434.1K $1.847K
YoY Change 3.77% -96.39%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$434.1K -$340.1K
YoY Change 3.77% 5.86%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -13.28M -$26.76M
YoY Change 380.32% 406.74%
NET CHANGE
Cash From Operating Activities -4.395M $38.61M
Cash From Investing Activities -434.1K -$340.1K
Cash From Financing Activities -13.28M -$26.76M
Net Change In Cash -18.11M $11.51M
YoY Change -637.68% -218.96%
FREE CASH FLOW
Cash From Operating Activities -$4.395M $38.61M
Capital Expenditures $434.1K $1.847K
Free Cash Flow -$4.829M $38.61M
YoY Change -178.74% -1035.83%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q1 us-gaap Liabilities Current
LiabilitiesCurrent
92941541 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
187268687 usd
CY2024Q1 us-gaap Other Long Term Debt Noncurrent
OtherLongTermDebtNoncurrent
250000 usd
CY2023Q4 us-gaap Other Long Term Debt Noncurrent
OtherLongTermDebtNoncurrent
250000 usd
CY2024Q1 us-gaap Labor And Related Expense
LaborAndRelatedExpense
11025040 usd
CY2023Q1 us-gaap Labor And Related Expense
LaborAndRelatedExpense
11573990 usd
CY2024Q1 us-gaap Revenues
Revenues
46978634 usd
CY2024Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
750000000 shares
CY2024Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
750000000 shares
CY2024Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
5777853 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
5826206 shares
CY2024Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
5635178 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
5697517 shares
CY2024Q1 us-gaap Common Stock Value
CommonStockValue
2084 usd
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
2085 usd
CY2024Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
186288172 usd
CY2023Q2 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
0.02631579
CY2022 us-gaap Accounting Standards Update Extensible List
AccountingStandardsUpdateExtensibleList
http://fasb.org/us-gaap/2023#AccountingStandardsUpdate201613Member
CY2023Q2 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
0.02631579
CY2024Q1 szl Financing Receivable Installment Payment Plan Installment Period
FinancingReceivableInstallmentPaymentPlanInstallmentPeriod
P14D
CY2023Q2 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
0.02631579
CY2024Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
516330 usd
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
625471 usd
CY2024Q1 us-gaap Assets
Assets
195708421 usd
CY2023Q4 us-gaap Assets
Assets
212645283 usd
CY2024Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
73732665 usd
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
74135491 usd
CY2024Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
50431 usd
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
57316 usd
CY2024Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
10488273 usd
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
10790308 usd
CY2024Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
5536037 usd
CY2023Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
5261436 usd
CY2024Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
3134135 usd
CY2023Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
2643230 usd
CY2023Q4 us-gaap Deferred Finance Costs Current Net
DeferredFinanceCostsCurrentNet
619094 usd
CY2024Q1 us-gaap Deferred Finance Costs Current Net
DeferredFinanceCostsCurrentNet
619094 usd
CY2024Q1 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
0 usd
CY2023Q4 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
94380906 usd
CY2024Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
884227 usd
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
981692 usd
CY2024Q1 us-gaap Deferred Finance Costs Noncurrent Net
DeferredFinanceCostsNoncurrentNet
561194 usd
CY2023Q4 us-gaap Deferred Finance Costs Noncurrent Net
DeferredFinanceCostsNoncurrentNet
561194 usd
CY2024Q1 us-gaap Long Term Line Of Credit
LongTermLineOfCredit
71438806 usd
CY2023Q4 us-gaap Long Term Line Of Credit
LongTermLineOfCredit
0 usd
CY2024Q1 szl Class Of Warrant Or Right Warrant Liabilities Noncurrent
ClassOfWarrantOrRightWarrantLiabilitiesNoncurrent
0 usd
CY2023Q4 szl Class Of Warrant Or Right Warrant Liabilities Noncurrent
ClassOfWarrantOrRightWarrantLiabilitiesNoncurrent
967257 usd
CY2024Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
580456 usd
CY2023Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1083323 usd
CY2024Q1 us-gaap Liabilities
Liabilities
166095030 usd
CY2023Q4 us-gaap Liabilities
Liabilities
190550959 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
186015079 usd
CY2024Q1 us-gaap Common Stock Shares Subscribed But Unissued
CommonStockSharesSubscribedButUnissued
658 shares
CY2023Q4 us-gaap Common Stock Shares Subscribed But Unissued
CommonStockSharesSubscribedButUnissued
0 shares
CY2024Q1 us-gaap Stockholders Equity Note Subscriptions Receivable
StockholdersEquityNoteSubscriptionsReceivable
38848 usd
CY2023Q4 us-gaap Stockholders Equity Note Subscriptions Receivable
StockholdersEquityNoteSubscriptionsReceivable
0 usd
CY2024Q1 szl Transaction Expense
TransactionExpense
11787146 usd
CY2023Q1 szl Transaction Expense
TransactionExpense
8238586 usd
CY2024Q1 us-gaap Information Technology And Data Processing
InformationTechnologyAndDataProcessing
2157172 usd
CY2023Q1 us-gaap Information Technology And Data Processing
InformationTechnologyAndDataProcessing
1749176 usd
CY2024Q1 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
654875 usd
CY2023Q1 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
3199174 usd
CY2024Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
2379778 usd
CY2023Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
2798210 usd
CY2024Q1 us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
5139966 usd
CY2023Q1 us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
1694364 usd
CY2024Q1 us-gaap Costs And Expenses
CostsAndExpenses
33143977 usd
CY2023Q1 us-gaap Costs And Expenses
CostsAndExpenses
29253500 usd
CY2024Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
13834657 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
5419931 usd
CY2024Q1 us-gaap Interest Expense
InterestExpense
4081442 usd
CY2023Q1 us-gaap Interest Expense
InterestExpense
3377047 usd
CY2024Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-91560 usd
CY2023Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
113487 usd
CY2024Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
1261556 usd
CY2023Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
420201 usd
CY2024Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
8400099 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1736170 usd
CY2024Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
393094 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
11624 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
8007005 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
1724546 usd
CY2024Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
1451 usd
CY2023Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-145808 usd
CY2024Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
8008456 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
1578738 usd
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.41
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.31
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.34
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.31
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5660199 shares
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5480673 shares
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
5960768 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
5556830 shares
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
8843246 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2148085 usd
CY2023Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
750 usd
CY2023Q1 szl Stock Issued During Period Value Restricted Stock Units Vested In Period
StockIssuedDuringPeriodValueRestrictedStockUnitsVestedInPeriod
242023 usd
CY2023Q1 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
28918 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
1724546 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
13662501 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
22094324 usd
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
757029 usd
CY2024Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
171816 usd
CY2024Q1 szl Stock Issued During Period Value Restricted Stock Units Vested In Period
StockIssuedDuringPeriodValueRestrictedStockUnitsVestedInPeriod
148215 usd
CY2024Q1 szl Stock Issued During Period Value Stock Subscriptions Collectable On Options Exercised
StockIssuedDuringPeriodValueStockSubscriptionsCollectableOnOptionsExercised
0 usd
CY2024Q1 szl Adjustments To Additional Paid In Capital Conversion Of Warrant Liability To Stockholders Equity
AdjustmentsToAdditionalPaidInCapitalConversionOfWarrantLiabilityToStockholdersEquity
2228813 usd
CY2024Q1 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
3481077 usd
CY2024Q1 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
314185 usd
CY2024Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
1451 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
8007005 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
29613391 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
8007005 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
1724546 usd
CY2024Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
226816 usd
CY2023Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
200768 usd
CY2024Q1 us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
5139966 usd
CY2023Q1 us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
1694364 usd
CY2024Q1 us-gaap Provision For Other Credit Losses
ProvisionForOtherCreditLosses
1078409 usd
CY2023Q1 us-gaap Provision For Other Credit Losses
ProvisionForOtherCreditLosses
516319 usd
CY2024Q1 us-gaap Share Based Compensation
ShareBasedCompensation
905244 usd
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
2390108 usd
CY2024Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
195617 usd
CY2023Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
173453 usd
CY2024Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
1261556 usd
CY2023Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
420201 usd
CY2024Q1 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
17289 usd
CY2023Q1 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-2174 usd
CY2024Q1 us-gaap Increase Decrease In Finance Receivables
IncreaseDecreaseInFinanceReceivables
-21952935 usd
CY2023Q1 us-gaap Increase Decrease In Finance Receivables
IncreaseDecreaseInFinanceReceivables
-6885554 usd
CY2024Q1 us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
823724 usd
CY2023Q1 us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
-128749 usd
CY2024Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-866677 usd
CY2023Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-1013216 usd
CY2024Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-174394 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-17748691 usd
CY2024Q1 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
277626 usd
CY2023Q1 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-952451 usd
CY2024Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-796803 usd
CY2023Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-647194 usd
CY2024Q1 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
491107 usd
CY2023Q1 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
120447 usd
CY2024Q1 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
22265 usd
CY2023Q1 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
3700 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
38613013 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-4074737 usd
CY2024Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1847 usd
CY2023Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
51158 usd
CY2024Q1 us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
338229 usd
CY2023Q1 us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
270095 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-340076 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-321253 usd
CY2024Q1 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
0 usd
CY2023Q1 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
11300000 usd
CY2024Q1 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
23000000 usd
CY2023Q1 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
16500000 usd
CY2024Q1 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
137717 usd
CY2023Q1 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
52883 usd
CY2024Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
171816 usd
CY2023Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
750 usd
CY2024Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
3795262 usd
CY2023Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
28918 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-26761163 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-5281051 usd
CY2024Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-25917 usd
CY2023Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
735157 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
11511774 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-9677041 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
70699223 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
69522658 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
82185080 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
60580774 usd
CY2024Q1 szl Noncash Or Part Noncash Acquisition Conversion Of Warrant Liabilities To Stockholders Equity
NoncashOrPartNoncashAcquisitionConversionOfWarrantLiabilitiesToStockholdersEquity
2228813 usd
CY2023Q1 szl Noncash Or Part Noncash Acquisition Conversion Of Warrant Liabilities To Stockholders Equity
NoncashOrPartNoncashAcquisitionConversionOfWarrantLiabilitiesToStockholdersEquity
0 usd
CY2024Q1 us-gaap Interest Paid Net
InterestPaidNet
4167381 usd
CY2023Q1 us-gaap Interest Paid Net
InterestPaidNet
3617351 usd
CY2024Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
0 usd
CY2023Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
825 usd
CY2024Q1 us-gaap Revenues
Revenues
46978634 usd
CY2024Q1 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 segment
CY2024Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1 segment
CY2024Q1 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Reclassifications</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain prior period amounts have been reclassified to conform with the current period presentation format. These reclassifications had no effect on our total assets, net income, or total comprehensive income.</span></div>
CY2024Q1 us-gaap Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss
FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss
112514403 usd
CY2023Q4 us-gaap Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss
FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss
142885682 usd
CY2023Q1 us-gaap Revenues
Revenues
34673431 usd
CY2024Q1 us-gaap Revenue Not From Contract With Customer
RevenueNotFromContractWithCustomer
21732600 usd
CY2024Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
25246034 usd
CY2023Q1 us-gaap Revenue Not From Contract With Customer
RevenueNotFromContractWithCustomer
24232411 usd
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
10441020 usd
CY2023Q1 us-gaap Revenues
Revenues
34673431 usd
CY2024Q1 us-gaap Financing Receivable Deferred Income
FinancingReceivableDeferredIncome
2662864 usd
CY2023Q4 us-gaap Financing Receivable Deferred Income
FinancingReceivableDeferredIncome
3340150 usd
CY2024Q1 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
3134135 usd
CY2023Q4 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
2643230 usd
CY2024Q1 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
2490449 usd
CY2024Q1 szl Consumer Installment Payment Plans Number Of Installments
ConsumerInstallmentPaymentPlansNumberOfInstallments
4 installment
CY2024Q1 szl Financing Receivables Receivables Due Duration
FinancingReceivablesReceivablesDueDuration
P42D
CY2024Q1 szl Number Of Product Segments
NumberOfProductSegments
1 product
CY2024Q1 us-gaap Financing Receivable Before Allowance For Credit Loss And Fee
FinancingReceivableBeforeAllowanceForCreditLossAndFee
115177267 usd
CY2023Q4 us-gaap Financing Receivable Before Allowance For Credit Loss And Fee
FinancingReceivableBeforeAllowanceForCreditLossAndFee
146225832 usd
CY2024Q1 us-gaap Financing Receivable Deferred Income
FinancingReceivableDeferredIncome
2662864 usd
CY2023Q4 us-gaap Financing Receivable Deferred Income
FinancingReceivableDeferredIncome
3340150 usd
CY2024Q1 us-gaap Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss
FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss
112514403 usd
CY2023Q4 us-gaap Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss
FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss
142885682 usd
CY2024Q1 szl Financing Receivable Excluding Accrued Interest Weighted Average Days Outstanding
FinancingReceivableExcludingAccruedInterestWeightedAverageDaysOutstanding
P34D
CY2024Q1 us-gaap Financing Receivable Excluding Accrued Interest Year One Originated Current Fiscal Year
FinancingReceivableExcludingAccruedInterestYearOneOriginatedCurrentFiscalYear
107868752 usd
CY2024Q1 us-gaap Financing Receivable Excluding Accrued Interest Year Two Originated Fiscal Year Before Current Fiscal Year
FinancingReceivableExcludingAccruedInterestYearTwoOriginatedFiscalYearBeforeCurrentFiscalYear
4645651 usd
CY2024Q1 us-gaap Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss
FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss
112514403 usd
CY2023Q4 us-gaap Financing Receivable Excluding Accrued Interest Year One Originated Current Fiscal Year
FinancingReceivableExcludingAccruedInterestYearOneOriginatedCurrentFiscalYear
142882717 usd
CY2023Q4 us-gaap Financing Receivable Excluding Accrued Interest Year Two Originated Fiscal Year Before Current Fiscal Year
FinancingReceivableExcludingAccruedInterestYearTwoOriginatedFiscalYearBeforeCurrentFiscalYear
2965 usd
CY2023Q4 us-gaap Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss
FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss
142885682 usd
CY2023Q4 us-gaap Financing Receivable Allowance For Credit Loss Excluding Accrued Interest
FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest
12253041 usd
CY2022Q4 us-gaap Financing Receivable Allowance For Credit Loss Excluding Accrued Interest
FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest
10223451 usd
CY2024Q1 us-gaap Financing Receivable Excluding Accrued Interest Credit Loss Expense Reversal
FinancingReceivableExcludingAccruedInterestCreditLossExpenseReversal
5139966 usd
CY2023Q1 us-gaap Financing Receivable Excluding Accrued Interest Credit Loss Expense Reversal
FinancingReceivableExcludingAccruedInterestCreditLossExpenseReversal
1694364 usd
CY2024Q1 us-gaap Financing Receivable Excluding Accrued Interest Allowance For Credit Loss Writeoff
FinancingReceivableExcludingAccruedInterestAllowanceForCreditLossWriteoff
9027008 usd
CY2023Q1 us-gaap Financing Receivable Excluding Accrued Interest Allowance For Credit Loss Writeoff
FinancingReceivableExcludingAccruedInterestAllowanceForCreditLossWriteoff
6119010 usd
CY2024Q1 us-gaap Financing Receivable Excluding Accrued Interest Allowance For Credit Loss Recovery
FinancingReceivableExcludingAccruedInterestAllowanceForCreditLossRecovery
816733 usd
CY2023Q1 us-gaap Financing Receivable Excluding Accrued Interest Allowance For Credit Loss Recovery
FinancingReceivableExcludingAccruedInterestAllowanceForCreditLossRecovery
1331537 usd
CY2024Q1 us-gaap Financing Receivable Allowance For Credit Loss Excluding Accrued Interest
FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest
9182732 usd
CY2023Q1 us-gaap Financing Receivable Allowance For Credit Loss Excluding Accrued Interest
FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest
6251765 usd
CY2024Q1 us-gaap Financing Receivable Excluding Accrued Interest Year One Originated Current Fiscal Year Writeoff
FinancingReceivableExcludingAccruedInterestYearOneOriginatedCurrentFiscalYearWriteoff
133887 usd
CY2024Q1 us-gaap Financing Receivable Excluding Accrued Interest Year Two Originated Fiscal Year Before Current Fiscal Year Writeoff
FinancingReceivableExcludingAccruedInterestYearTwoOriginatedFiscalYearBeforeCurrentFiscalYearWriteoff
8889273 usd
CY2024Q1 us-gaap Financing Receivable Excluding Accrued Interest Year Three Originated Two Years Before Current Fiscal Year Writeoff
FinancingReceivableExcludingAccruedInterestYearThreeOriginatedTwoYearsBeforeCurrentFiscalYearWriteoff
3735 usd
CY2024Q1 us-gaap Financing Receivable Excluding Accrued Interest Year Four Originated Three Years Before Current Fiscal Year Writeoff
FinancingReceivableExcludingAccruedInterestYearFourOriginatedThreeYearsBeforeCurrentFiscalYearWriteoff
113 usd
CY2024Q1 us-gaap Financing Receivable Excluding Accrued Interest Year Five Originated Four Years Before Current Fiscal Year Writeoff
FinancingReceivableExcludingAccruedInterestYearFiveOriginatedFourYearsBeforeCurrentFiscalYearWriteoff
0 usd
CY2024Q1 us-gaap Financing Receivable Excluding Accrued Interest Revolving Writeoff
FinancingReceivableExcludingAccruedInterestRevolvingWriteoff
9027008 usd
CY2024Q1 szl Financing Receivable Excluding Accrued Interest Year One Originated Current Fiscal Year Recoveries
FinancingReceivableExcludingAccruedInterestYearOneOriginatedCurrentFiscalYearRecoveries
0 usd
CY2024Q1 szl Financing Receivable Excluding Accrued Interest Year Two Originated Fiscal Year Before Current Fiscal Year Recoveries
FinancingReceivableExcludingAccruedInterestYearTwoOriginatedFiscalYearBeforeCurrentFiscalYearRecoveries
504583 usd
CY2024Q1 szl Financing Receivable Excluding Accrued Interest Year Three Originated Two Years Before Current Fiscal Year Recoveries
FinancingReceivableExcludingAccruedInterestYearThreeOriginatedTwoYearsBeforeCurrentFiscalYearRecoveries
151385 usd
CY2024Q1 szl Financing Receivable Excluding Accrued Interest Year Four Originated Three Years Before Current Fiscal Year Recoveries
FinancingReceivableExcludingAccruedInterestYearFourOriginatedThreeYearsBeforeCurrentFiscalYearRecoveries
125307 usd
CY2024Q1 szl Financing Receivable Excluding Accrued Interest Year Five Originated Four Years Before Current Fiscal Year Recoveries
FinancingReceivableExcludingAccruedInterestYearFiveOriginatedFourYearsBeforeCurrentFiscalYearRecoveries
35458 usd
CY2024Q1 szl Financing Receivable Excluding Accrued Interest Revolving Recoveries
FinancingReceivableExcludingAccruedInterestRevolvingRecoveries
816733 usd
CY2024Q1 szl Financing Receivable Excluding Accrued Interest Year One Originated Current Fiscal Year Write Off Recoveries Net
FinancingReceivableExcludingAccruedInterestYearOneOriginatedCurrentFiscalYearWriteOffRecoveriesNet
133887 usd
CY2024Q1 szl Financing Receivable Excluding Accrued Interest Year Two Originated Fiscal Year Before Current Fiscal Year Write Off Recoveries Net
FinancingReceivableExcludingAccruedInterestYearTwoOriginatedFiscalYearBeforeCurrentFiscalYearWriteOffRecoveriesNet
8384690 usd
CY2024Q1 szl Financing Receivable Excluding Accrued Interest Year Three Originated Two Years Before Current Fiscal Year Write Off Recoveries Net
FinancingReceivableExcludingAccruedInterestYearThreeOriginatedTwoYearsBeforeCurrentFiscalYearWriteOffRecoveriesNet
-147650 usd
CY2024Q1 szl Financing Receivable Excluding Accrued Interest Year Four Originated Three Years Before Current Fiscal Year Write Off Recoveries Net
FinancingReceivableExcludingAccruedInterestYearFourOriginatedThreeYearsBeforeCurrentFiscalYearWriteOffRecoveriesNet
-125194 usd
CY2024Q1 szl Financing Receivable Excluding Accrued Interest Year Five Originated Four Years Before Current Fiscal Year Write Off Recoveries Net
FinancingReceivableExcludingAccruedInterestYearFiveOriginatedFourYearsBeforeCurrentFiscalYearWriteOffRecoveriesNet
-35458 usd
CY2024Q1 szl Financing Receivable Excluding Accrued Interest Revolving Write Off Recoveries Net
FinancingReceivableExcludingAccruedInterestRevolvingWriteOffRecoveriesNet
8210275 usd
CY2024Q1 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
1316330 usd
CY2023Q4 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
1571728 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
8007005 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
1724546 usd
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5660199 shares
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5480673 shares
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
5960768 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
5556830 shares
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.41
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.31
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.34
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.31
CY2024Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
85741 shares
CY2023Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
228281 shares
CY2024Q1 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q1 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2024Q1 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0001662991-24-000143-index-headers.html Edgar Link pending
0001662991-24-000143-index.html Edgar Link pending
0001662991-24-000143.txt Edgar Link pending
0001662991-24-000143-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
R9999.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
szl-20240331.htm Edgar Link pending
szl-20240331.xsd Edgar Link pending
szl-20240331_g1.jpg Edgar Link pending
szl-20240331_def.xml Edgar Link unprocessable
szl-20240331_lab.xml Edgar Link unprocessable
szl-20240331_htm.xml Edgar Link completed
szl-20240331_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
szl-20240331_cal.xml Edgar Link unprocessable